{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T21:01:15Z","timestamp":1784581275773,"version":"3.55.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004324","name":"Astellas Pharma Inc","doi-asserted-by":"publisher","award":["RS01442"],"award-info":[{"award-number":["RS01442"]}],"id":[{"id":"10.13039\/100004324","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010795","name":"Chugai Pharmaceutical Co Ltd","doi-asserted-by":"publisher","award":["AC-1-20150630164707-161208"],"award-info":[{"award-number":["AC-1-20150630164707-161208"]}],"id":[{"id":"10.13039\/100010795","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002336","name":"Daiichi Sankyo Company Limited","doi-asserted-by":"publisher","award":["A16-0602"],"award-info":[{"award-number":["A16-0602"]}],"id":[{"id":"10.13039\/501100002336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007638","name":"Kidney Foundation Japan","doi-asserted-by":"publisher","award":["JKFB 15-43"],"award-info":[{"award-number":["JKFB 15-43"]}],"id":[{"id":"10.13039\/501100007638","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004948","name":"Astellas Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004948","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["kireports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International Reports"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ekir.2026.106558","type":"journal-article","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T15:33:54Z","timestamp":1776872034000},"page":"106558","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["ABO Blood Types and Mortality in Patients Undergoing Hemodialysis"],"prefix":"10.1016","volume":"11","author":[{"given":"Masafumi","family":"Kurajoh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuo","family":"Shoji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Nakatani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Nagata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisako","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuo","family":"Imanishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Emoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoaki","family":"Morioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ekir.2026.106558_bib1","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/s41581-022-00542-7","article-title":"Epidemiology of haemodialysis outcomes","volume":"18","author":"Bello","year":"2022","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.ekir.2026.106558_bib2","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/s41581-020-0315-4","article-title":"The current and future landscape of dialysis","volume":"16","author":"Himmelfarb","year":"2020","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.ekir.2026.106558_bib3","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1053\/j.ajkd.2024.06.017","article-title":"Explaining international trends in mortality on hemodialysis through changes in hemodialysis practices in the dialysis outcomes and practice patterns study (DOPPS)","volume":"85","author":"McCullough","year":"2025","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ekir.2026.106558_bib4","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.ajkd.2003.07.016","article-title":"Malnutrition-inflammation complex syndrome in dialysis patients: causes and consequences","volume":"42","author":"Kalantar-Zadeh","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ekir.2026.106558_bib5","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0272-6386(00)70200-9","article-title":"C-reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients","volume":"35","author":"Yeun","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ekir.2026.106558_bib6","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1186\/s12882-020-02026-x","article-title":"Risk factors for mortality in elderly haemodialysis patients: a systematic review and meta-analysis","volume":"21","author":"Song","year":"2020","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.ekir.2026.106558_bib7","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1538-7836.2007.02818.x","article-title":"ABO(H) blood groups and vascular disease: a systematic review and meta-analysis","volume":"6","author":"Wu","year":"2008","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.ekir.2026.106558_bib8","article-title":"ABO blood group system and the coronary artery disease: an updated systematic review and meta-analysis","volume":"6","author":"Chen","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.ekir.2026.106558_bib9","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s12916-014-0237-8","article-title":"Mortality and cancer in relation to ABO blood group phenotypes in the Golestan Cohort Study","volume":"13","author":"Etemadi","year":"2015","journal-title":"BMC Med"},{"key":"10.1016\/j.ekir.2026.106558_bib10","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/6629060","article-title":"Human ABO blood groups and their associations with different diseases","volume":"2021","author":"Abegaz","year":"2021","journal-title":"BioMed Res Int"},{"key":"10.1016\/j.ekir.2026.106558_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2020.100785","article-title":"The impact of ABO blood group on COVID-19 infection risk and mortality: A systematic review and meta-analysis","volume":"48","author":"Liu","year":"2021","journal-title":"Blood Rev"},{"key":"10.1016\/j.ekir.2026.106558_bib12","doi-asserted-by":"crossref","first-page":"4412","DOI":"10.1038\/s41598-017-04046-4","article-title":"ABO blood type correlates with survival in hepatocellular carcinoma following hepatectomy","volume":"7","author":"Wu","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.ekir.2026.106558_bib13","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1093\/ndt\/gfab247","article-title":"Associations of cardiovascular disease and blood pressure with cognition in hemodialysis patients: the Osaka Dialysis Complication Study","volume":"37","author":"Shoji","year":"2022","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ekir.2026.106558_bib14","doi-asserted-by":"crossref","first-page":"343","DOI":"10.3390\/nu14020343","article-title":"Association between levocarnitine treatment and the change in knee extensor strength in patients undergoing hemodialysis: A post-hoc analysis of the Osaka Dialysis Complication Study (ODCS)","volume":"14","author":"Matsufuji","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.ekir.2026.106558_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.xkme.2024.100914","article-title":"The surprise question in hemodialysis, frailty, nutrition, patient-reported quality of life, and all-cause mortality: the Osaka Dialysis Complication Study (ODCS)","volume":"6","author":"Shoji","year":"2024","journal-title":"Kidney Med"},{"key":"10.1016\/j.ekir.2026.106558_bib16","doi-asserted-by":"crossref","first-page":"3776","DOI":"10.3390\/nu16213776","article-title":"Associations of cognitive function with serum magnesium and phosphate in hemodialysis patients: A cross-sectional analysis of the Osaka Dialysis Complication Study (ODCS)","volume":"16","author":"Shoji","year":"2024","journal-title":"Nutrients"},{"key":"10.1016\/j.ekir.2026.106558_bib17","doi-asserted-by":"crossref","first-page":"3270","DOI":"10.3390\/nu16193270","article-title":"Association between serum zinc and all-cause mortality in patients undergoing maintenance hemodialysis: the Osaka Dialysis Complication Study (ODCS)","volume":"16","author":"Nakatani","year":"2024","journal-title":"Nutrients"},{"key":"10.1016\/j.ekir.2026.106558_bib18","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1007\/s10157-025-02735-3","article-title":"Estimated T50 calciprotein crystallization test in patients undergoing hemodialysis: Osaka Dialysis Complication Study (ODCS)","volume":"29","author":"Shoji","year":"2025","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.ekir.2026.106558_bib19","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1038\/s41440-019-0284-9","article-title":"The Japanese Society of Hypertension guidelines for the management of hypertension (JSH 2019)","volume":"42","author":"Umemura","year":"2019","journal-title":"Hypertens Res"},{"key":"10.1016\/j.ekir.2026.106558_bib20","doi-asserted-by":"crossref","first-page":"641","DOI":"10.5551\/jat.GL2022","article-title":"Japan Atherosclerosis Society (JAS) guidelines for prevention of atherosclerotic cardiovascular diseases 2022","volume":"31","author":"Okamura","year":"2024","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.ekir.2026.106558_bib21","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.ekir.2026.106558_bib22","first-page":"677","article-title":"Mortality rates among patients with end-stage renal disease in Canada, 1981\u201386","volume":"141","author":"Silins","year":"1989","journal-title":"CMAJ"},{"key":"10.1016\/j.ekir.2026.106558_bib23","doi-asserted-by":"crossref","first-page":"592","DOI":"10.3390\/biomedicines11020592","article-title":"NonA blood type is a risk factor for poor cardio-cerebrovascular outcomes in patients undergoing dialysis","volume":"11","author":"Nakayama","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.ekir.2026.106558_bib24","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.atherosclerosis.2010.03.012","article-title":"ABO blood group alleles: A risk factor for coronary artery disease. An angiographic study","volume":"211","author":"Carpeggiani","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ekir.2026.106558_bib25","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1046\/j.1365-3148.2001.00315.x","article-title":"The relationship between ABO histo-blood group, factor VIII and von Willebrand factor","volume":"11","author":"O\u2019Donnell","year":"2001","journal-title":"Transfus Med"},{"key":"10.1016\/j.ekir.2026.106558_bib26","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1161\/ATVBAHA.116.308225","article-title":"Von Willebrand factor, ADAMTS13, and the risk of mortality: the Rotterdam study","volume":"36","author":"Sonneveld","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ekir.2026.106558_bib27","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1111\/jth.13071","article-title":"Elevated levels of factor VIII and subsequent risk of all-cause mortality: results from the MEGA follow-up study","volume":"13","author":"Yap","year":"2015","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.ekir.2026.106558_bib28","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1007\/s11239-012-0719-5","article-title":"Relationship between ABO blood groups and von Willebrand factor, ADAMTS13 and factor VIII in patients undergoing hemodialysis","volume":"33","author":"Rios","year":"2012","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.ekir.2026.106558_bib29","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1093\/ndt\/gfr735","article-title":"Plasma concentration of von Willebrand factor predicts mortality in patients on chronic renal replacement therapy","volume":"27","author":"Pequeriaux","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ekir.2026.106558_bib30","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0009-8981(91)90303-T","article-title":"Serum levels of human alkaline phosphatase isozymes in relation to blood groups","volume":"203","author":"Domar","year":"1991","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.ekir.2026.106558_bib31","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1007\/s10157-024-02540-4","article-title":"Comparison of serum alkaline phosphatase levels between two measurement methods in chronic hemodialysis patients in Japan: involvement of ABO blood group system and relationship with mortality risk","volume":"28","author":"Nagano","year":"2024","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.ekir.2026.106558_bib32","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1681\/ASN.2008010014","article-title":"Serum alkaline phosphatase predicts mortality among maintenance hemodialysis patients","volume":"19","author":"Regidor","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2026.106558_bib33","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1093\/ndt\/gfu055","article-title":"A higher serum alkaline phosphatase is associated with the incidence of hip fracture and mortality among patients receiving hemodialysis in Japan","volume":"29","author":"Maruyama","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ekir.2026.106558_bib34","article-title":"Inflammation and cardiovascular disease associated with hemodialysis for end-stage renal disease","volume":"13","author":"Wang","year":"2022","journal-title":"Front Pharmacol"},{"issue":"suppl 1","key":"10.1016\/j.ekir.2026.106558_bib35","doi-asserted-by":"crossref","first-page":"S96","DOI":"10.1053\/ajkd.2003.50094","article-title":"Vascular calcification in dialysis patients: pathogenesis and consequences","volume":"41","author":"Reslerova","year":"2003","journal-title":"Am J Kidney Dis"},{"issue":"suppl 3","key":"10.1016\/j.ekir.2026.106558_bib36","doi-asserted-by":"crossref","first-page":"iii6","DOI":"10.1093\/ndt\/gfy179","article-title":"Large uremic toxins: an unsolved problem in end-stage kidney disease","volume":"33","author":"Wolley","year":"2018","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ekir.2026.106558_bib37","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1186\/s12882-025-04401-y","article-title":"Biocompatibility in hemodialysis: artificial membrane and human blood interactions","volume":"26","author":"Avila","year":"2025","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.ekir.2026.106558_bib38","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1046\/j.1523-1755.2003.00803.x","article-title":"Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients","volume":"63","author":"Kalantar-Zadeh","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.ekir.2026.106558_bib39","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.nephro.2008.01.005","article-title":"Reverse epidemiology in hemodialysis patients. Lessons from Japanese registries","volume":"4","author":"Shoji","year":"2008","journal-title":"Nephrol Ther"},{"key":"10.1016\/j.ekir.2026.106558_bib40","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-068984","article-title":"Frequency and distribution of ABO and Rh blood group systems among blood donors at the Northern Zone Blood Transfusion Center in Kilimanjaro, Tanzania: a retrospective cross-sectional study","volume":"13","author":"Vuhahula","year":"2023","journal-title":"BMJ Open"},{"key":"10.1016\/j.ekir.2026.106558_bib41","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/BF02001790","article-title":"The distribution of the ABO blood groups in Japan","volume":"23","author":"Fujita","year":"1978","journal-title":"Jinrui Idengaku Zasshi"},{"key":"10.1016\/j.ekir.2026.106558_bib42","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1002\/ajpa.20887","article-title":"An ancient DNA test of a founder effect in Native American ABO blood group frequencies","volume":"137","author":"Halverson","year":"2008","journal-title":"Am J Phys Anthropol"},{"key":"10.1016\/j.ekir.2026.106558_bib43","doi-asserted-by":"crossref","first-page":"4635","DOI":"10.1182\/blood-2010-01-261859","article-title":"The relationship between blood groups and disease","volume":"115","author":"Anstee","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.ekir.2026.106558_bib44","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s13054-018-2022-0","article-title":"The impact of blood type O on mortality of severe trauma patients: a retrospective observational study","volume":"22","author":"Takayama","year":"2018","journal-title":"Crit Care"},{"key":"10.1016\/j.ekir.2026.106558_bib45","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-95443-3","article-title":"The impact of blood type on the mortality of patients with severe abdominal trauma: a multicenter observational study","volume":"11","author":"Takayama","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.ekir.2026.106558_bib46","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13613-021-00844-2","article-title":"ABO blood types and sepsis mortality","volume":"11","author":"Itenov","year":"2021","journal-title":"Ann Intensive Care"},{"key":"10.1016\/j.ekir.2026.106558_bib47","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.ejvs.2012.11.022","article-title":"ABO blood type does not influence the risk of cardiovascular complications and mortality after vascular surgery","volume":"45","author":"Bakker","year":"2013","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.ekir.2026.106558_bib48","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/ejh.14329","article-title":"ABO blood type and short-term mortality in patients with infection-associated disseminated intravascular coagulation","volume":"114","author":"Flaeng","year":"2025","journal-title":"Eur J Haematol"}],"container-title":["Kidney International Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468024926027907?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468024926027907?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T20:01:19Z","timestamp":1784577679000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468024926027907"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":48,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S2468024926027907"],"URL":"https:\/\/doi.org\/10.1016\/j.ekir.2026.106558","relation":{},"ISSN":["2468-0249"],"issn-type":[{"value":"2468-0249","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ABO Blood Types and Mortality in Patients Undergoing Hemodialysis","name":"articletitle","label":"Article Title"},{"value":"Kidney International Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ekir.2026.106558","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of the International Society of Nephrology.","name":"copyright","label":"Copyright"}],"article-number":"106558"}}